The MFCS™-EZ is a unique pressure-based flow controller for micro-fluidic and nano-fluidic applications.
The Chromium Genome uses the power of Linked-Reads to fully resolve genic phasing, reveal structural variation and detect variants in previously inaccessible and complex regions of the genome.
University of Michigan researchers have found that direct to consumer genetic testing customers find their results useful, rather than alarming.
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Biosensors containing up to 100 stacked layers of antibodies offer greater sensitivity.
New resource will greatly accelerate scientific discovery and the rate of wheat improvement.
Researchers provide evidence that mild traumatic brain injury is associated with greater neurodegeneration and reduced memory performance in people genetically at risk of Alzheimer's Disease.
ARIAD Pharmaceuticals today announced it has entered into a definitive agreement to be acquired by Takeda Pharmaceutical Company.
Jan 18 - Jan 19, 2017